Phase II Clinical Trial of SHR-1139 Injection in Patients With Psoriasis
Phase II Clinical Trial of SHR-1139 Injection in Patients With Psoriasis
Recruiting · NCT07719530 · Registry updated 2026-08-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase II Clinical Trial of SHR-1139 Injection in Patients With Psoriasis | Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, psoriasis, skin disorder | Recruiting | Phase 2 | 2026-08-20 | NCT07719530 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Guangdong Hengrui Pharmaceutical Co., Ltd | 31 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Dermatology Hospital Hospital of Southern Medical University | Guangzhou | China | 1 |